Etanercept Biosimilar Safe and Effectively Treats RA - DocWire News

Etanercept Biosimilar Safe and Effectively Treats RA  DocWire News

The results of a recent trial found that patients with moderate-to-severe rheumatoid arthritis (RA) who switched from etanercept (ETN) to biosimilar sandoz.



Comments

Post a Comment

Popular posts from this blog